MedTrace Logo

Calcium Phosphate Cement Registry (CPC Registry)

NCT02575352 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2018-05-25

No results posted yet for this study

Summary

CPC REGISTRY is a multi-center, international, prospective, open-label, observational study on the use of injectable calcium phosphate cements for the treatment of bone defects in adults. All patients will be treated with any of the two injectable calcium phosphate bone substitutes (GRAFTYS®HBS/GRAFTYS®Quickset or their private labels) according to standard clinical practice and according to the information provided by GRAFTYS manufacturer in respective device Instructions For Use (IFU).

Conditions

  • Bone Disease
  • Fracture Bone
  • Bone Cyst

Sponsors & Collaborators

  • Clinfile

    collaborator INDUSTRY

  • Graftys SA

    lead INDUSTRY

Principal Investigators

  • Sébastien PARRATTE, MD, Prof · Hospital of "LA TIMONE"

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • France
  • Germany
  • Italy
  • Martinique
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02575352 on ClinicalTrials.gov